Skip to main content
Erschienen in: Annals of Hematology 8/2018

17.02.2018 | Letter to the Editor

Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma

verfasst von: Tomonori Nakazato, Satoshi Takanashi, Motoharu Hirano, Chisako Ito, Yuriko Fujita, Yuki Osada, Yoshinobu Aisa, Takehiko Mori

Erschienen in: Annals of Hematology | Ausgabe 8/2018

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Literatur
1.
Zurück zum Zitat Tokuhira M, Watanabe R, Nemoto T, Sagawa M, Tomikawa T, Tamaru JI, Itoyama S, Nagasawa H, Amano K, Kameda H, Takeuchi T, Mori S, Kizaki M (2012) Clinicopathological analysis in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53:616–623CrossRefPubMed Tokuhira M, Watanabe R, Nemoto T, Sagawa M, Tomikawa T, Tamaru JI, Itoyama S, Nagasawa H, Amano K, Kameda H, Takeuchi T, Mori S, Kizaki M (2012) Clinicopathological analysis in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis. Leuk Lymphoma 53:616–623CrossRefPubMed
2.
Zurück zum Zitat Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K (2013) Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91:20–28CrossRefPubMed Ichikawa A, Arakawa F, Kiyasu J, Sato K, Miyoshi H, Niino D, Kimura Y, Takeuchi M, Yoshida M, Ishibashi Y, Nakashima S, Sugita Y, Miura O, Ohshima K (2013) Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol 91:20–28CrossRefPubMed
3.
Zurück zum Zitat Gion Y, Iwaki N, Tanaka K et al (2017) Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci 108:1271–1280CrossRefPubMedPubMedCentral Gion Y, Iwaki N, Tanaka K et al (2017) Clinicopathological analysis of methotrexate-associated lymphoproliferative disorders: comparison of diffuse large B-cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci 108:1271–1280CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Vachhani P, Bose N, Brodeur JP, Holkova B, Bose P (2014) Remission of rheumatoid arthritis on brentuximab vedotin. Rheumatology 53:2314–2315CrossRefPubMed Vachhani P, Bose N, Brodeur JP, Holkova B, Bose P (2014) Remission of rheumatoid arthritis on brentuximab vedotin. Rheumatology 53:2314–2315CrossRefPubMed
5.
Zurück zum Zitat Gerli R, Muscat C, Bistoni O, Falini B, Tomassini C, Agea E, Tognellini R, Biagini P, Bertotto A (1995) High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol 102:547–550CrossRefPubMedPubMedCentral Gerli R, Muscat C, Bistoni O, Falini B, Tomassini C, Agea E, Tognellini R, Biagini P, Bertotto A (1995) High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol 102:547–550CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C (2000) CD30+ T cells in rheumatoid arthritis: mechanisms of recruitment and functional role. J Immunol 164:4399–4407CrossRefPubMed Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C (2000) CD30+ T cells in rheumatoid arthritis: mechanisms of recruitment and functional role. J Immunol 164:4399–4407CrossRefPubMed
Metadaten
Titel
Brentuximab vedotin is effective for rheumatoid arthritis in a patient with relapsed methotrexate-associated Hodgkin lymphoma
verfasst von
Tomonori Nakazato
Satoshi Takanashi
Motoharu Hirano
Chisako Ito
Yuriko Fujita
Yuki Osada
Yoshinobu Aisa
Takehiko Mori
Publikationsdatum
17.02.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Annals of Hematology / Ausgabe 8/2018
Print ISSN: 0939-5555
Elektronische ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-018-3279-8

Weitere Artikel der Ausgabe 8/2018

Annals of Hematology 8/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.